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ABSTRACT
Wound healing is a complex process involving an integrated response by many
different cell types and growth factors in order to achieve rapid restoration of
skin architecture and function. The present study evaluated the applicability of a
chitosan hydrogel (CH) as a wound dressing. Scanning electron microscopy anal-
ysis was used to characterize CH morphology. Fibroblast cells isolated from rat
skin were used to assess the cytotoxicity of the hydrogel. CH was able to promote
cell adhesion and proliferation. Cell viability studies showed that the hydrogel
and its degradation by-products are noncytotoxic. The evaluation of the appli-
cability of CH in the treatment of dermal burns in Wistar rats was performed by
induction of full-thickness transcutaneous dermal wounds. Wound healing was
monitored through macroscopic and histological analysis. From macroscopic
analysis, the wound beds of the animals treated with CH were considerably
smaller than those of the controls. Histological analysis revealed lack of a reactive
or a granulomatous inflammatory reaction in skin lesions with CH and the ab-
sence of pathological abnormalities in the organs obtained by necropsy, which
supported the local and systemic histocompatibility of the biomaterial. The
present results suggest that this biomaterial may aid the re-establishment of skin
architecture.
Skin lesions are traumatic events that lead to the increase
of fluid loss, hypothermia, scarring, locally immunocom-
promised regions, infections, and a change of body image.1
Despite advances in therapy, infections remain a leading
cause of morbidity and mortality in burn patients.2
After skin damage, wound healing is a complex biolog-
ical process, which includes a wide range of mechanisms,
such as coagulation, inflammation, matrix synthesis
and deposition, angiogenesis, fibroplasia, epithelialization,
contraction, and remodeling.1,3 In spite of its complexity,
regeneration of skin is often imperfect and the wound is
mainly covered by scar tissue.4
The replacement of damaged tissues requires biocom-
patible materials on which cells may adhere and prolifer-
ate. Such materials include natural polymers extracted
from the native extracellular matrix (ECM), like collagens
and glycosaminoglycans.4 However, some of these materi-
als, due to their chemical and biological inertness, may be
unable to induce cell adhesion and proliferation. It is well
known that adhesion and proliferation of cells to bioma-
terials is highly dependent on the topography of the sub-
stratum and its surface properties, namely its surface
charge, surface free energy and density, along with the na-
ture of its polar groups.5,6
In the past decades, many skin substitutes such as xeno-
graft, allografts, and autografts have been used for the
treatment of deep partial- and full-thickness wounds.
However, due to the antigenicity or the limitation of do-
nor sites, skin substitutes cannot accomplish the purpose
of skin regeneration and hence are not widely used.7
Nowadays, none of the skin substitutes available or un-
der development are able to fully substitute natural living
skin.8
Chitosan is the deacetylated derivative of chitin, a nat-
ural polysaccharide found primarily in the exoskeletons of
arthropods and some fungi.9 It is a linear polysaccharide
comprising copolymers of glucosamine and N-acetyl glu-
cosamine linked by b (1–4) glycosidic bonds. The molar
fraction of glucosamine residues is referred to as the degree
of deacetylation (DD).10,11 In its crystalline form, chitosan
is normally insoluble in an aqueous solution above pH 7;
however, in diluted acids (pH 6.0), the protonated
free amino groups on glucosamine facilitate solubility of
the molecule. Chitosan preparations of various molecular
weights (50–2,000 kDa), degrees of deacetylation (30–
95%), and further molecular derivatization patterns allow
extensive adjustment of mechanical and biological
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properties. These properties include anticholesterolemic
and antimicrobial activity, biocompatibility, biodegrad-
ability, fungistatic, hemostasis, noncarcinogenic, remark-
able affinity to proteins, stimulation of healing, tissue
engineering scaffolds, and drug delivery.2,3,12–15
Recently, there has been a growing interest in the chem-
ical modification of chitosan in order to improve its solu-
bility and widen its applications.16 Different studies have
reported the use of chitosan for skin tissue engineering.13
Ueno et al.17 showed that chitosan in the form of chito-
san-cotton accelerates wound healing by promoting infil-
tration of polymorphonuclear cells at the wound site. In
recent studies, chitosan has been used to deliver bioactive
molecules: basic fibroblast growth factor18 and human
epidermal growth factor12 were encapsulated in this bio-
material; electrospun nonwoven nanofibrous hybrid mats
based on chitosan and poly[(L-lactide)-co-(D,L-lactide)]
were produced;19 chitosan dressing incorporating a proco-
agulant (polyphosphate) and an antimicrobial (silver);15
and chitosan acetate bandages were used as a topical an-
timicrobial dressing for infected burns.2
MATERIALS AND METHODS
Hydrogel synthesis
Chitosan (average MZ5270,000Da and deacetylation de-
gree 86%) was obtained from Cognis (Monheim am
Rhein, Germany). Lactic acid (> 99.0%) was purchased
from HiMedia (Mumbai, India). Ammonium hydroxide
solution at 25% (puriss. p.a.) was acquired from Fluka
(Buch, Switzerland).
The chitosan hydrogel (CH) was produced adapting the
method described previously by Montembault et al.11
Briefly, to prepare the CH, a chitosan solution 4% (w/w)
was dispersed in lactic acid 2% (v/v) to achieve the stoic-
hiometric protonation of the NH2 sites, followed by ag-
itation until complete dissolution. The solution was left
overnight in order for the air bubbles to collapse com-
pletely. Chitosan solution was poured into several small
molds (147 cm), 30 g per mold. The molds were placed
inside a hermetic chamber, together with 4L of ammonia
solution, 2.5% (v/v). The chitosan solutions were left ex-
posed to ammonia vapor overnight. The hydrogels were
rinsed with distilled water, removed from the molds, and
placed in watch glasses for 5 hours in order for the excess
ammonia to evaporate. The prepared CH was packed sep-
arately and sealed in plastic bags. The samples were la-
beled and sterilized by UV radiation for 30 minutes. The
packed, sterilized CH was then maintained at room tem-
perature in a dry and clean place until use.
Scanning electron microscopy
The morphologies of CH with/without adhered fibroblasts
cells isolated from rat skin were characterized by scanning
electron microscopy (SEM). CH and their adherent fibro-
blasts were fixed overnight with 2.5% glutaraldehyde in
phosphate-buffered saline (PBS) at 4 1C. Samples were
rinsed three times with PBS buffer for 2 minutes and de-
hydrated in graded ethanol (ETOH) of 70, 80, 90, and
100%, 5 minutes each. Then, hydrogels were mounted on
an aluminum board using a double-sided adhesive tape
and sputter coated with gold using an Emitech K550
(London, England) sputter coater. The samples were ana-
lyzed using a Hitachi S-2700 (Tokyo, Japan) scanning
electron microscope operated at an accelerating voltage
of 20 kV at various magnifications.
Cell source and growth
Fibroblast cells from rat skin were obtained as reported
previously.20 The operative skin area was shaved and dis-
infected using 70% ETOH. Skin samples were aseptically
removed from the rats and stored in RPMI-1640 (Gibco,
Grand Island, NY) medium with penicillin G (100U/mL),
streptomycin (100mg/mL), and amphotericin B (0.25 mg/
mL). Then, the samples were minced and incubated for 3
hours in 0.1% collagenase solution (37 1C, 5%CO2). After
incubation, the samples were centrifuged (5 minutes,
250 g), the supernatant was discarded, and the pellet
was washed with Dulbecco’s modified Eagle’s medium
(DMEM)-F12 supplemented with heat-inactivated fetal
bovine serum (FBS, 10% v/v). The isolated cells were
plated in 25 cm3 T-flasks with DMEM-F12 medium (1 : 1
v/v) supplemented with heat-inactivated FBS (10%v/v),
L-glutamine (2mM), penicillin G (100U/mL), streptomy-
cin (100mg/mL), and amphotericin B (0.25 mg/mL).
After 2 hours, the nonadherent cells were washed out.
Cells were kept in culture at 37 1C, in a humidified atmo-
sphere, 5% CO2. After confluence was attained, cells were
subcultivated by a 5-minute incubation in 0.18% trypsin
(1 : 250) and 5mM EDTA. The free cells were added to an
equal volume of culture medium. Following centrifuga-
tion, cells were resuspended in sufficient culture medium.
Proliferation of fibroblast cells in the presence of CH
To examine cell proliferation, fibroblast cells were cultured
in 24-well plates at 1105 cells/mL for 24 hours. Cell
growth was monitored using an Olympus CX41 (Tokyo,
Japan) inverted light microscope equipped with an Olym-
pus SP-500 UZ digital camera and SEM images were also
acquired.
Determination of hydrogel cytotoxicity by 3-[4,5-
dimethyl-thiazol-2-yl]-2,5-diphenyltetrazolium
bromide (MTT) assay
CH was applied to a 96-well plate (Nunc, Roskilde, Den-
mark). The plates were UV irradiated for 30 minutes,
before cell seeding.
Second passage rat fibroblasts cells were seeded in a 96-
well plate containing the biomaterial at a density of 6104
cells per well. Then, 100mL of culture medium was added
to each well and the plate was incubated at 37 1C, in a 5%
CO2 humidified atmosphere, for 24 hours. After incuba-
tion, the mitochondrial redox activity was assessed
through the reduction of the MTT (n56). Fifty microliters
of MTT (5mg/mL PBS) was added to each sample, fol-
lowed by incubation for 4 hours at 37 1C, in a 5% CO2 at-
mosphere. The medium was aspirated and cells were
treated with 50mL of isopropanol/HCl (0.04N) for 90
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minutes. Absorbance at 570 nm was measured using a Bio-
rad Microplate Reader Benchmark (Tokyo, Japan).
Wells containing cells in the culture medium without
biomaterials were used as negative control. ETOH 96%
was added to wells containing cells as a positive control.
Animal experiments
A total of 18 female Wistar rats (8–10 weeks) were used,
weighing between 200 and 250 g at the time of the exper-
iments. The animal protocols followed in the present study
were approved by the Ethics Committee of Centro Hospit-
alar Cova da Beira and were performed according to the
guidelines set forth in the National Institutes of Health
Guide for the care and use of laboratory animals.
Rats were individually anesthetized via an IP injection
(40mg/kg ketamine, 5mg/kg xylazine) for surgery and in-
duction of the burn wound. The operative skin area was
shaved and disinfected using ETOH. Then, the dorsal skin
of the animal was exposed to water at 95 1 1C for 10 sec-
onds. After 2 hours, damaged tissue was removed with
surgical scissors and forceps. Wounds of 2 cm diameter
were created with no visible bleeding. The animals were
divided into two groups: in group 1, wounds were filled
with CH and finally fixed with elastic bandage; group 2
was used as control and wounds were covered with PBS
and an elastic bandage.
After surgery, animals were kept in separate cages and
were fed with commercial rat food and water ad libitum.
All animals showed good general health condition
throughout the study, as assessed by their weight gain.
The animals were sacrificed after 7, 14, and 21 days.
Histological study
The material from the skin lesions and organs (brain,
heart, lung, liver, spleen, and kidney) obtained by nec-
ropsy was formalin fixed and paraffin embedded for rou-
tine histological processing. A 3mm section obtained from
each paraffin block was stained with hematoxylin and eo-
sin (H&E) and evaluated in a blinded manner by two ob-
servers using a light microscope with specific image
analysis software from Olympus. For the morphological
evaluation of skin lesions, three parameters were consid-
ered: wound bed length, thickness of the granulation tissue
layer, and thickness of the epithelial layer. In the assess-
ment of the three parameters it was always considered the
greatest dimension observed. Skin fragments with no CH
were used as normal control. The assessment of the brain,
heart, liver, lung, kidney, and spleen was performed by
looking for any morphological alteration.
Evaluation of the wound size
Images of the wound area were taken by a digital camera
(Nikon D50, Ayuthaya, Thailand) and analyzed with im-
age analysis software Image J (Scion Corp., Frederick,
MD). Measurement of the wound closure area was defined
by the limits of grossly evident epithelialization, with all
surface areas in a two-dimensional plane calibrated
against the adjacent metric ruler. The percentage of wound
size was calculated using the following formula: DN/D0
100 (%), where D0 is the dimension of the full-thickness
circular skin wound area (2 cm diameter) on day 0 and DN
is the dimension of the wound area on the indicated day.
Figure 1. Photograph of chitosan
hydrogel (CH) (A) and scanning elec-
tron microscopic images of CH sur-
face morphology (B–D). Original
magnification: (A) scale bar 1 cm; (B)
50, scale bar 100mm; (C) 2,000,
scale bar 5mm; (D) 3,000, scale bar
5 mm.
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Statistical analysis
In each measurement of the surface area of the burn
wounds, a minimum of three animals were used. The
results obtained were expressed as mean standard error
of the mean. Differences between groups were tested by
one-way ANOVA with Dunnet’s post hoc test. Computa-
tions were performed using a MYSTAT 12 statistical




From gross observation, the CH was white, opaque, and
presented a dense outer layer, as shown in Figure 1A. The
dense outer layer of hydrogel provides several functions
such as control of the water loss through evaporation and
protection from external contamination, as reported pre-
viously in the literature.12
SEM analysis (Figure 1B–D) revealed a highly porous
and interconnected interior structure. It could be inferred
that the hydrogel has a high water-retention capacity be-
cause high DD chitosan (86%) can establish H-bonds with
water. Both small and macromolecules could freely diffuse
into CH.
Cytotoxicity of CH
In order to study the applicability of our new hydrogel for
biomedical applications, the cytocompatibility of CH was
first studied through in vitro studies. Fibroblasts were
seeded at the same initial density in the 96-well plates, with
or without hydrogel, on day 0, to assess the CH cytoxicity.
After 24 hours, cell adhesion and proliferation was visual-
ized using an inverted light microscope (Figure 2). Fibro-
blast cells adhere and grow in the vicinity of CH (Figure
2A and B) and in the negative control (Figure 2C). In the
positive control, no cell adhesion or proliferation was ob-
served. Dead cells with their typical spherical shape can be
observed in Figure 2D.
Figure 2. Photomicrographs of fibro-
blast cells from rat skin after being
seeded on chitosan hydrogel (CH) af-
ter 24 hours (A) and 3 days (B); poly-
styrene (C); and polystyrene with
ethanol 96% (D). Original magnifica-
tion 100, scale bar 1mm.
Figure 3. Scanning electron photo-
micrographs of fibroblasts adhered
on the surface of chitosan hydrogel.
Original magnification: (A) 1,000,
scale bar 10 mm; (B) 4,500 scale
bar 1mm.
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SEM images were acquired to further examine and
characterize cell adhesion to CH. Cell growth and filopo-
dia were observed, indicating that cells were attached and
spread on hydrogels after 24 hours (Figure 3A) and 7 days
(Figure 3B). Because of their large volume, the fibroblasts
could not penetrate into the pore cavity and remained on
the surface of CH. Fibroblasts synthesize and organize an
ECM, which is fundamental for the repair of the
lesion and avoid formation of hypertrophic scars and
keloids.4
To further evaluate the biocompatibility of the CH, an
MTT assay was also performed (Figure 4). The MTT as-
say showed a significant difference between cells exposed
to CH and the positive control (p < 0.05) after 24 hours of
incubation, suggesting that the hydrogel did not affect cell
viability. These results show that the tested formulation
does not have an acute cytotoxic effect.
Acceleration of wound healing by CH in rats
transcutaneous full-thickness dermal wounds
In vivo experiments showed that CH adhered uniformly to
the freshly excised wound surface, as reported previously
in the literature.21 In the inflammatory phase, chitosan has
unique hemostatic properties that are independent of the
normal coagulation cascade.3,22
Figure 5 shows a set of typical wound beds shortly after
the surgical procedure and application of the hydrogel.
The healing patterns were observed after 2, 6, 9, 13, 15,
and 21 days and showed that the topical application of
chitosan improved wound healing. The wound area de-
creased rapidly in the presence of hydrogel when com-
pared with the control (Figures 5 and 6). The results
obtained were statistically significant until day 9.
Histological study
The results of the histological study are summarized in
Figure 7. The analysis of histological data (Figure 8)
showed that the maximum and minimum values for
wound bed length and granulation tissue thickness
were obtained on days 14 and 21, respectively. Epithelial
layer thickness increased progressively from days 7 to
21. On day 21, all the skin lesions exhibited complete
epithelialization. Neither specific inflammation nor reac-
tive granulomas to the presence of CH were observed. No
Figure 4. Cellular activities measured by the 3-[4,5-dimethyl-
thiazol-2-yl]-2,5-diphenyltetrazolium bromide assay. K1, posi-
tive control; K, negative control; CH, chitosan hydrogel. Fibro-
blast cells in the presence of biomaterial. Each result is the
mean standard error of the mean of at least three indepen-
dent experiments. Statistical analysis was performed using
one-way ANOVA with Dunnet’s post hoc test (np < 0.05).
Figure 5. Typical macroscopic wound-
healing panorama with different treat-
ments over 21 days. One deep third-
degree burn wound with 2cm diame-
ter at the dorsal skin of female Wistar
rats, treated with chitosan hydrogel (A)
and phosphate-buffered saline. (B). All
went through various healing phases
such as inflammation, eschar, tissue
formation and tissue remodeling on
the 2nd, 6th, 9th, 13th, 15th, and 21st
day after injury.
Figure 6. Effect of chitosan hydrogel and phosphate-buffered
saline on burn wound. The surface area of the burn wounds
was calculated as described in methods and reported at each
time point as the percentage of the surface area at baseline.
Each point represents the mean standard error of the mean
of at least three independent experiments. nChitosan vs. con-
trol (p < 0.05, one-way ANOVA with Dunnet’s post-hoc test).
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microorganisms were observed in skin lesions. No patho-
logical abnormalities were observed in the brain, heart,
liver, lung, kidney, and spleen obtained during necropsy.
DISCUSSION
Wound healing is a dynamic process that typically evolves
from its initial inflammatory response to complete resolu-
tion and thus, healing.23 Hydrogels, with their high water
contents and retention capacity, appear to be optimal me-
dia to enhance wound healing,23,24 and thus, considerable
interest has been focused on developing hydrogel-based
wound dressings from biomaterials.23,25
In the present work, a CH was prepared through a re-
cent development of the method described previously in
the literature.11 Chitosan is considered as an appropriate
functional material for biomedical applications because of
high biocompatibility, biodegradability, nonantigenicity,
and adsorption properties. Anti-inflammatory or allergic
reactions have not been observed in human subjects fol-
lowing topical application, implantation, injection, and in-
gestion.26 In previous studies, Montembault et al.11
reported that the percentage of DD and polymer concen-
tration influences the mechanism of gelation of CH. For
high DD, the high charge density is responsible for strong
electrostatic repulsions, which do not favor the formation
of physical junctions between chain segments. The present
hydrogel was mainly built by hydrogen bonding. In high
concentrated polymer solutions, chains become entangled,
and hydrogel forms rapidly.27 Lactic acid was added to in-
duce the stoichiometric protonation of the NH2 sites.
Keeping in mind the wound dressing application, the
porous section of CH (Figure 1) promotes drainage, pre-
vents the build-up of exudates, and may be an optimum
wound bed for autografting. Moreover, the porosity of
CH promotes gas exchange, which is fundamental for the
wound-healing process. A high CO2 pressure increases the
acidity and slows down the healing process, and in addi-
tion, a low oxygen concentration decreases the regenera-
tion of tissue cell or facilitates the proliferation of
anaerobic bacteria.22 Our CH appears to be particularly
interesting for the proposed biomedical application,
because it behaves as a decoy of biological media, both
due to its physical form and its chemical structure. Indeed,
the b (1–4) glycosidic linkage and the N-acetyl groups are
present in the structure of extra-cellular matrixes.27
The observation of cell growth in the presence of CH
(Figures 2 and 3) revealed the importance of the method
used to obtain the present hydrogel, because previous
studies reported that there is no evidence that chitosan28
or chitosan-coated membranes4 can support adhesion and
proliferation of fibroblasts in vitro. It is well known that
the surface chemistry of hydrogels can affect cell adhesion,
proliferation, and other phenomena.6 Chitosan used to
produce CH presents a DD of 86%, which is responsible
for CH being positively charged at the surface. Hamilton
et al.29 reported that increased N-acetylation of chitosan
changes the physical properties of chitosan, as it becomes
less positively charged and more hydrophobic. The high
DD of CH allows electrostatic interactions of cationic
NH3
1 groups with anionic glycosaminoglycans, proteogly-
cans, and other negatively charged molecules that are pres-
ent in the cell membranes.30 Because skin has a negative
charge and CH is a cation polymer, it can bind electrostat-
ically to the skin, as reported previously in the literature.31
These electrostatic interactions are fundamental for the
suitability of the material for the function proposed herein.
In vitro and in vivo cytocompatibility studies revealed
that CH and its degradation by-products are biocompati-
ble, suggesting that CH has no cytotoxic effect.
Figure 7. Graph with results of the histological analysis. For
the morphological evaluation of skin lesions, three parameters
were considered: wound bed length, thickness of the granula-
tion tissue layer, and thickness of the epithelial layer. Skin frag-
ments with no chitosan hydrogel (CH) were used as control.
Figure 8. Hematoxylin and eosin-
stained sections of biopsies for the
morphological evaluation of skin le-
sions. CH-treated wound on the 7th
day, scale bar 500mm (A), at 14th
day, scale bar 200mm (C), and at
21st day, scale bar 200mm (E). Con-
trol wound on the 7th day (B), on the
14th day (D), and on the 21st day (F),
scale bar 500 mm. CH, chitosan
hydrogel, EP, epithelial layer, GT,
granulation tissue, NE, new epithe-
lial layer; WL, wound length.
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From macroscopic analysis, the wound beds of the an-
imals treated with CH were considerably smaller as com-
pared with those of the controls treated with PBS.
Macroscopic findings did not reveal a significant differ-
ence in terms of the wound contraction area after day 9.
The wound area of the control animals increased during
the first days (Figure 6), which was not observed in the an-
imals treated with CH. Therefore, this supports the pro-
moting role of CH in wound healing. These results
corroborate what has been reported previously in the lit-
erature.32–34
In the histological study, the lack of a reactive or a
granulomatous inflammatory reaction in skin lesions with
CH and the absence of pathological abnormalities in the
organs obtained by necropsy supported the local and sys-
temic histocompatibility of the biomaterial. Furthermore,
the increasing thickness of the epithelial layer during the
experiment and the presence of complete epithelialization
in all the skin samples treated by CH suggest that this bio-
material may aid the re-establishment of tissue architec-
ture. In addition, the absence of microorganisms in skin
lesions, after CH treatment, supports the previously de-
scribed antimicrobial properties of CH2 and supports its
role in skin repair.
Further studies will be required to clarify the clinical
significance of these findings for wound healing. The addi-
tion of grafted dermal fibroblasts to this natural polymer
may aid the remodeling of wounds and their perfect heal-
ing, as demonstrated for a number of skin substitutes.
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